Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Andrea Scioscia, MD

Andrea Scioscia, MD

  • Associate Program Director, Pediatric Critical Care Medicine, UH Rainbow Babies and Children's Hospital
  • Clinical Instructor, CWRU School of Medicine
  • Assistant Professor, CWRU School of Medicine

Biography: Andrea Scioscia, MD

Certifications & Memberships

  • Pediatrics - American Board of Pediatrics

Education

Fellowship | Pediatric Critical Care Medicine
Pediatric Critical Care Medicine - Children's Hospital Of Pittsburgh Of UPMC (2019 - 2022)

Residency | Pediatrics/Chief Resident
Pediatrics/Chief Resident - UH Cleveland Medical Center (2018 - 2019)

Residency | Pediatrics
Pediatrics - UH Cleveland Medical Center (2015 - 2018)

Medical Education
Drexel University College Of Medicine (2015)

Undergraduate
Williams College (2010)

About

Andrea Scioscia, MD, MS, joined the PICU faculty at University Hospitals Rainbow Babies & Children’s in 2022. She is an Assistant Professor in Pediatrics, Case Western Reserve University. She is also the Associate Program Director for the pediatric critical care fellowship.

Dr. Scioscia completed her Master of Science in Medical Education in 2022. She serves as education director for the unit, coordinating interdisciplinary teaching among critical care APPs, nurses, pharmacists and trainees. She is also a member of the Association of Pediatric Program Directors (APPD). Her research interests include patient/family communication, curriculum development and implementation and simulation.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Andrea Scioscia did not disclose any Outside Relationships with Industry.